| | english | español | français |
Go to record ID

  Home|Finding Information|Record details   Printer-friendly version

Risk Assessment
Record information and status
Record ID
116096
Status
Published
Date of creation
2021-06-11 01:13 UTC (lorelieu5@gmail.com)
Date of publication
2021-06-11 01:13 UTC (lorelieu5@gmail.com)

General Information
Country
  • Philippines
Title of risk assessment
Determination for the Safety Assessment of COTTON GHB811 for Direct Use as Food, Feed and for Processing
Date of the risk assessment
Date not available
Competent National Authority(ies) responsible for the risk assessment
Department of Agriculture
Elliptical Road, Diliman
Quezon City
Philippines, 1100
Phone:+632 920-3986,+632 924-1278 local 2802
Fax:+632 920-3986
Email:osec.da@gmail.com
Url:DA
Risk assessment details
Living modified organism
BCS-GH811-4 - Herbicide tolerant cotton
Resistance to herbicides - Glyphosate
Scope of the risk assessment
  • LMOs for direct use as feed
  • LMOs for direct use as food
  • LMOs for processing
Methodology and points to consider
Potential adverse effects identified in the risk assessment
Certain fatty acid forms like sterculic, malvalic and dihydrosterculic acids are found in cotton. These are classified as anti-nutrients.

Gossypol is a toxic substance in cottonseed and its by-product meal.
Likelihood that the potential adverse effects will be realized
SDS-PAGE and western blot analysis showed that digestibility of HPPD W336 in simulated gastric fluid (SGF) with pepsin at pH 1.2 is within 30 seconds after incubation. It was also assessed in simulated intestinal fluid (SIF) with pancreatinin at pH 7.5. Results showed that the 90% of the protein was completely broken down in less than 30 seconds of incubation. These results indicate that it is unlikely to cause toxicological risk to human health.

Bioinformatics analyses using FASTA algorithm associated with the BLOSUM50 scoring matrix sequence alignment tool showed that no relevant structural similarities were observed between the HPPD W336 and human and animal toxins. This indicates that HPPD W336 will not cause toxicity or health risk to human health.

No Observed Effect Level (NOEL) for 2mEPSPS protein was observed at 2000 mg/kg body weight, with no signs of treatment-related clinical signs and no changes in food consumption. The mean food consumption of the treated samples was significantly lower in both sexes compared to control, but the values were within normal range.
Possible consequences:
Two in silico approaches using the FASTA algorithm with BLOSUM50 scoring matrix were used. Based on the bioinformatics analysis, there are no toxicological in silico findings associated with the 2mEPSPS protein. Acute oral toxicity was also performed in male and female C57BL/6J mice. There were no mortalities, no treatment-related clinical signs, no effects on the body weight and food consumption parameters as well as no macroscopic changes in necropsy in C57BL/6J mice after acute oral administration of the 2mEPSPS protein at 2000 mg/kg body weight.

Again, two in silico approaches using the FASTA algorithm with BLOSUM50 scoring matrix were used to check HPPD W336 for homology with known allergens. Based on the bioinformatics analysis, there are no allergenic in silico findings associated with the HPPD W336 protein.
Recommendation(s)
Bioinformatics analyses using FASTA algorithm associated with the BLOSUM50 scoring matrix sequence alignment tool showed that no relevant structural similarities were observed between the HPPD W336 and human and animal toxins. This indicates that HPPD W336 will not cause toxicity or health risk to human.

Further, acute oral toxicity assessment was then conducted using E. coli-produced HPPD W336 protein in 6 male and 6 female C57BL/6J mice at a total dose level of 2000 mg/kg body weight [5]. Based on the toxicity study, there were no treatment-related effects on survival, clinical observations, body weight gain, food consumption or gross pathology, thus the NOAEL for HPPD W336 was 2000 mg/kg bw, the highest dose tested.

Find no evidence that COTTON GHB811 applied for human food and animal feed use is as safe as its conventional counterpart and shall not pose any significant risk to human and animal health.
A biosafety permit for direct use can be issued for the said event.
Need(s) for further information on specific issues of concern
With the use of two in silico approaches using FASTA algorithm with BLOSUM50 scoring matrix, an overall identity search with all protein sequences in NCBI non-redundant and internal toxin databases with E-value threshold of 0.1 and 10, respectively was performed to assess if the double mutated 5-enol pyruvylshikimate-3-phosphate synthase (2mEPSPS) protein has a similarity with known toxins. Results in general protein database showed various proteins from different origins but has no potential hazard recorded.
Receiving environment(s) considered
The application of COTTON GHB811 is not for propagation. This LMO will be directly used for food, feed and for processing.

The direct use of the regulated article whether for food, feed or for processing will not cause any significant adverse effect on the environment and biodiversity. The transgenic crop will not increase its weediness potential in case the seeds spill out into the environment because cotton has limited potential to survive outside agricultural settings, and the introduced genes are not expected to increase its ability to spread and persist.

The genetically modified crop is substantially similar to its conventional counterpart except for the herbicide tolerance trait.
LMO detection and identification methods proposed
Diagnostic lateral flow strips, ELISA and PCR for routine qualitative and semi-quantitative detection of transgenes. For higher sensitivity, real-time PCR methods may be used.
Additional Information
Additional Information
COTTON GHB811 is intended for direct use as food, feed and for processing.

All relevant references were submitted by the technology developer in their application; other references requested by the Scientific and Technical Review Panel (STRP) members during the evaluation of this combined trait product were provided.
Other relevant website address or attached documents